We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current XBIOW market cap is 12.33M. The company's latest EPS is USD -2.6833 and P/E is -1.42.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 487k | 606k | 651k | 611k | 672k |
| Operating Income | -1.56M | -915k | -1.2M | -1.15M | -1.26M |
| Net Income | -1.48M | -857k | -1.05M | -1.06M | -1.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 17k | 437k | 1.16M | 1.71M | 2.54M |
| Operating Income | -12.89M | -13.94M | -5.75M | -6.72M | -4.52M |
| Net Income | -18.06M | -10.89M | -5.65M | -6.55M | -4.14M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.72M | 13.72M | 12.75M | 11.96M | 10.61M |
| Total Liabilities | 1.07M | 856k | 871k | 1.07M | 809k |
| Total Equity | 13.65M | 12.86M | 11.88M | 10.89M | 9.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 21.55M | 13.18M | 19.82M | 14.72M | 10.61M |
| Total Liabilities | 4.33M | 963k | 1.42M | 1.07M | 809k |
| Total Equity | 17.21M | 12.22M | 18.39M | 13.65M | 9.8M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.65M | -1.1M | -2.37M | -3.32M | -4.11M |
| Investing | -500k | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.4M | -4.27M | -4.74M | -4.65M | -4.11M |
| Investing | 2k | N/A | N/A | -500k | N/A |
| Financing | 16.13M | 5.43M | 11.45M | N/A | N/A |
| Market Cap | 12.33M |
| Price to Earnings Ratio | -1.42 |
| Price to Sales Ratio | 2.31 |
| Price to Cash Ratio | 0.65 |
| Price to Book Ratio | 0.6 |
| Dividend Yield | - |
| Shares Outstanding | 1.54M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 10.9 (99.09%) |
| Company Name | Xenetic Biosciences Inc |
| Address |
3273 e warm springs road las vegas, nevada 89120 |
| Website | https://www.xeneticbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
